Turn Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Updates
(NasdaqGM:TTRX), Successfully began trading on NASDAQ under ticker TTRX on October 8, 2025 Strengthened its Board of Directors with the appointments of Arthur Golden and Dr. Kent Kester Entered into a global supply, development, and license agreement with leading medical-surgical product manufacturer and distributor Medline LOS ANGELES, Nov. 13, 2025 (GLOBE NEWSWIRE) — Turn Therapeutics […]